Bausch Health Cos
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Cos's score of 37 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bausch Health Cos's reported carbon emissions
In 2023, Bausch Health Cos reported total carbon emissions of approximately 49,906,000 kg CO2e for Scope 1, 51,990,000 kg CO2e for Scope 2 (market-based), and 27,107,000 kg CO2e for Scope 3 emissions related to waste generated in operations. This reflects a slight increase in Scope 1 emissions from 46,686,000 kg CO2e in 2022, while Scope 2 emissions (market-based) also rose from 50,513,000 kg CO2e in the previous year. Bausch Health has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2020 as the base year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the goal of limiting global warming to 1.5°C. The company also plans to measure and reduce its Scope 3 emissions, demonstrating a comprehensive approach to tackling its overall carbon footprint. These commitments position Bausch Health as a proactive player in the healthcare sector's response to climate change, reflecting a growing trend among companies to enhance sustainability practices and reduce greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
